Form 10 Explorer
10-Q
Quarterly Report
BIOMERICA, INC.

BMRA

NASDAQ

CIK: 73290

File #: 001-37863

Period End: Aug 31, 2025

Fiscal Year: 2026

View on EDGAR
Balance Sheet
35 line items · 2 periods
XBRL
ItemAug 31, 2025May 31, 2025
Assets
Current Assets:
Cash and Cash Equivalents
3,053,0002,399,000
Accounts Receivable
1,205,000731,000
Inventory
1,473,0001,490,000
Other Non-Operating Current Assets
168,000255,000
Total current assets
5,899,0004,875,000
Property, Plant and Equipment
120,000135,000
MEXICO
9,00010,000
Operating Lease Right-of-Use Asset
347,000429,000
Cash and Cash Equivalents
165,000165,000
Polish Distributor
165,000—
Intangible Assets
223,000228,000
Other Non-Operating Non-Current Assets
100,000113,000
Total Assets
6,854,0005,945,000
Liabilities and Shareholders’ Equity
Current Liabilities:
Accounts Payable
681,000672,000
Other Current Liabilities
591,000655,000
Other Current Liabilities
54,00055,000
Operating Lease Liability, Current
367,000358,000
Total current liabilities
1,693,0001,740,000
Operating Lease Liability, Non-Current
6,000100,000
Total Liabilities
1,699,0001,840,000
Shareholders’ Equity:
Total Stockholders' Equity
225,000203,000
Total Stockholders' Equity
58,198,00057,175,000
Total Stockholders' Equity
(102,000)(105,000)
Total Stockholders' Equity
(53,166,000)(53,168,000)
Total Shareholders’ Equity
5,155,0004,105,000
Common Stock
225,000203,000
Additional Paid-in Capital
58,198,00057,175,000
AOCI Attributable to Parent
(102,000)(105,000)
Retained Earnings
(53,166,000)(53,168,000)
Total Liabilities and Shareholders’ Equity
6,854,0005,945,000